Cargando…

Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells

Lung cancer is one of the leading causes of cancer-associated mortality, worldwide. The overall survival rate remains low, but progress has been made in improving the diagnosis and treatment of lung cancer over the past decades. Niclosamide, a salicylanilide derivative used for the treatment of tape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Mei, Chen, Zihong, Yang, Donghong, Li, Haiwen, Zuo, Yufang, Li, Jingjing, Zhang, Wendian, Zhou, Hechao, Jiang, Danxian, Xu, Zumin, Yu, Zhonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530112/ https://www.ncbi.nlm.nih.gov/pubmed/28781637 http://dx.doi.org/10.3892/ol.2017.6372

Ejemplares similares

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
por: Zhang, Wendian, et al.
Publicado: (2016)

Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression
por: Li, Jingjing, et al.
Publicado: (2018)

Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
por: Zuo, Yufang, et al.
Publicado: (2018)

Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2014)

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2015)

Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration
por: Shi, Zhenyi, et al.
Publicado: (2023)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats
por: Wang, Zhang, et al.
Publicado: (2013)

Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor–2α
por: Balaiya, Sankarathi, et al.
Publicado: (2012)

Paeoniflorin alleviates the progression of retinal vein occlusion via inhibiting hypoxia inducible factor-1α/vascular endothelial growth factor/STAT3 pathway
por: Kong, Lingchun, et al.
Publicado: (2022)

Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
por: Rofstad, E. K., et al.
Publicado: (1998)

Increased expression of hypoxia inducible factor-1 alpha and vascular endothelial growth factor is associated with diabetic gastroparesis
por: Wu, Xueping, et al.
Publicado: (2020)

Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients
por: Ni, Xiaojian, et al.
Publicado: (2013)

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022)

Case report of chemoradiotherapy combined with immunotherapy for liver metastasis and lymph node metastases in the head of the pancreas of nasopharyngeal carcinoma
por: Zhang, Jingtong, et al.
Publicado: (2022)

Effect of hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway on spinal cord injury in rats
por: Chen, Hailong, et al.
Publicado: (2017)

Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization
por: Lee, Christopher Seungkyu, et al.
Publicado: (2015)

Tongxinluo Inhibits Cyclooxygenase-2, Inducible Nitric Oxide Synthase, Hypoxia-inducible Factor-2α/Vascular Endothelial Growth Factor to Antagonize Injury in Hypoxia-stimulated Cardiac Microvascular Endothelial Cells
por: Li, Yan-Ning, et al.
Publicado: (2015)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
por: Pan, Jing-Xuan, et al.
Publicado: (2012)

Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization—Brief Report
por: Liyanage, Sidath E., et al.
Publicado: (2016)

Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia
por: Yu, Yue-Xin, et al.
Publicado: (2017)

Antitumor Effect on Human Gastric Cancer and Induction of Apoptosis by Vascular Endothelial Growth Factor Neutralizing Antibody
por: Kamiya, Kinji, et al.
Publicado: (1999)

Wide Spectrum of Antitumor Activity of a Neutralizing Monoclonal Antibody to Human Vascular Endothelial Growth Factor
por: Asano, Makoto, et al.
Publicado: (1999)

Antitumor Effect of a Neutralizing Antibody to Vascular Endothelial Growth Factor on Liver Metastasis of Endocrine Neoplasm
por: Konno, Hiroyuki, et al.
Publicado: (1998)

Hypoxia-Inducible Factor-1α Protects Cervical Carcinoma Cells from Apoptosis Induced by Radiation via Modulation of Vascular Endothelial Growth Factor and p53 under Hypoxia
por: Fu, Zhichao, et al.
Publicado: (2015)

Puerarin suppresses hypoxia-induced vascular endothelial growth factor upregulation in human retinal pigmented epithelial cells by blocking JAK2/STAT3 pathway
por: Tang, Huixin, et al.
Publicado: (2022)

Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
por: Sun, Yimeng, et al.
Publicado: (2021)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging
por: Alique, Matilde, et al.
Publicado: (2020)

Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway
por: Liu, Wenyue, et al.
Publicado: (2018)

The Clinicopathological Significance of Tissue Levels of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in Gastric Cancer
por: Kim, Seong-Eun, et al.
Publicado: (2009)

Expression and Function of Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor in Pulp Tissue of Teeth under Orthodontic Movement
por: Wei, Fulan, et al.
Publicado: (2015)

Binding interactions of niclosamide with serum proteins
por: Maltas, Esra
Publicado: (2014)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Desolvation Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023)

Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients
por: Almendros, Isaac, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g037d2l5kjem54cks7udj00blk